- Home
- AUROW vs VCEL Comparison
AUROW vs VCEL Comparison
Compare AUROW & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUROW | VCEL |
|---|---|---|
| Founded | 2017 | 1989 |
| Country | United States | United States |
| Employees | 1800 | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 2.0B |
| IPO Year | N/A | 1997 |
Fundamental Metrics
Financial Performance| Metric | AUROW | VCEL |
|---|---|---|
| Price | $0.31 | $36.39 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $60.40 |
| AVG Volume (30 Days) | 137.0K | ★ 611.4K |
| Earning Date | 04-30-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 236.54 |
| EPS | N/A | ★ 0.25 |
| Revenue | N/A | ★ $258,716,999.00 |
| Revenue This Year | N/A | $17.86 |
| Revenue Next Year | N/A | $18.55 |
| P/E Ratio | ★ N/A | $147.60 |
| Revenue Growth | N/A | ★ 14.05 |
| 52 Week Low | $2.09 | $29.24 |
| 52 Week High | $3.00 | $63.00 |
Technical Indicators
Market Signals| Indicator | AUROW | VCEL |
|---|---|---|
| Relative Strength Index (RSI) | 40.03 | 46.03 |
| Support Level | $0.31 | $34.79 |
| Resistance Level | $0.34 | $37.11 |
| Average True Range (ATR) | 0.04 | 1.38 |
| MACD | 0.01 | -0.28 |
| Stochastic Oscillator | 26.07 | 31.38 |
Price Performance
Historical ComparisonAbout AUROW Aurora Innovation Inc. Warrant
Aurora Innovation Inc delivers self-driving technology safely, quickly, and broadly. The Aurora Driver is a self-driving system designed to operate multiple vehicle types, from freight-hauling trucks to ride-hailing passenger vehicles. It underpins Aurora Horizon and Aurora Connect, its driver-as-a-service products for trucking and ride-hailing. The Company is developing the Aurora Driver, a scalable suite of self-driving hardware, software, and data services designed as a platform to adapt and interoperate among vehicle types and applications.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.